Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like The role of geroscience in understanding Alzheimer’s Disease October 10, 2024 The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy February 3, 2025 Healthcare utilization among the elderly remained stable in Japan despite pandemic challenges May 27, 2025
Healthcare utilization among the elderly remained stable in Japan despite pandemic challenges May 27, 2025